Antimicrobial resistance (AMR) has become a major challenge worldwide, particularly affecting people in low- and middle-income countries (LMICs) and vulnerable groups. Effective antimicrobials are of vital importance to human and animal health and should be viewed as a global commons.
What is microbial resistance?
Microbial resistance (AMR) occurs when microorganisms such as bacteria, viruses, fungi, and parasites become resistant to drugs. Due to AMR, medicines become ineffective and the infection becomes difficult to treat. This increases the risk of spreading infection, serious illness and death. Due to AMR, patients have to stay in hospitals for a long time and require intensive care. This increases pressure on health services and also increases health care costs.
Experts gave this information
A high-level meeting on antimicrobial resistance (AMR) was held in the United Nations General Assembly in 2024, in which microbial resistance (AMR) was discussed. On this we talked to some experts, who told that in the last few years, normal and restricted antibiotics are being used a lot, due to which their effect on people is gradually decreasing. ="text-align: justify;">How to get benefit?
High income and upper middle income countries need to ensure the allocation of domestic resources to reduce the impact of antimicrobial resistance (AMR). Countries with limited resources will need assistance in implementing national action plans. Resource mobilization will have to be promoted at the national and global level. Apart from this, political commitment, support and resource mobilization will have to be started.
Also read: Patients get great facilities in the Trauma Center of AIIMS, 100 new beds and five state-of-the-art operation theaters started.
Source link
